Clearance of iron oxide particles in rat liver - Effect of hydrated particle size and coating material on liver metabolism

被引:74
作者
Briley-Saebo, Karen C.
Johansson, Lars O.
Hustvedt, Svein Olaf
Haldorsen, Anita G.
Bjornerud, Atle
Fayad, Zahi A.
Ahlstrom, Haakan K.
机构
[1] CUNY Mt Sinai Sch Med, Imaging Sci Labs, New York, NY 10029 USA
[2] CUNY Mt Sinai Sch Med, Zena & Michael A Wiener Cardiovasc Inst, Marie Josee & Henry R Kravis Cardiovasc Hlth Ctr, New York, NY 10029 USA
[3] CUNY Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA
[4] Univ Uppsala Hosp, Dept Diagnost Radiol, Uppsala, Sweden
[5] GE Hlth Care, Oslo, Norway
[6] Aker Univ Hosp, Rikshosp, Dept Radiol, Oslo, Norway
关键词
iron oxide particles; liver; MRI;
D O I
10.1097/01.rli.0000221321.90261.09
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives: We sought to evaluate the effect of the particle size and coating material of various iron oxide preparations on the rate of rat liver clearance. Materials and Methods: The following iron oxide formulations were used in this study: dextran-coated ferumoxide (size = 97 nm) and ferumoxtran-10 (size = 21 nm), carboxydextran-coated SHU555A (size = 69 nm) and fractionated SHU555A (size = 12 nm), and oxidized-starch coated materials either unformulated NC100150 (size = 15 nm) or formulated NC100150 injection (size = 12 nm). All formulations were administered to 165 rats at 2 dose levels. Quantitative liver R-2* values were obtained during a 63-day time period. The concentration of iron oxide particles in the liver was determined by relaxometry, and these values were used to calculate the particle half-lives in the liver. Results: After the administration of a high dose of iron oxide, the half-life of iron oxide particles in rat liver was 8 days for dextran-coated materials, 10 days for carboxydextran materials, 14 days for unformulated oxidized-starch, and 29 days for formulated oxidized-starch. Conclusions: The results of the study indicate that materials with similar coating but different sizes exhibited similar rates of liver clearance. It was, therefore, concluded that the coating material significantly influences the rate of iron oxide clearance in rat liver.
引用
收藏
页码:560 / 571
页数:12
相关论文
共 62 条
[1]   Contrast-enhanced blood-pool MR angiography with optimized iron oxides: Effect of size and dose on vascular contrast enhancement in rabbits [J].
Allkemper, T ;
Bremer, C ;
Matuszewski, L ;
Ebert, W ;
Reimer, P .
RADIOLOGY, 2002, 223 (02) :432-438
[2]  
[Anonymous], 1993, US P, Patent No. 5262176
[3]   Magnetization exchange in capillaries by microcirculation affects diffusion-controlled spin-relaxation: A model which describes the effect of perfusion on relaxation enhancement by intravascular contrast agents [J].
Bauer, WR ;
Hiller, KH ;
Roder, F ;
Rommel, E ;
Ertl, G ;
Haase, A .
MAGNETIC RESONANCE IN MEDICINE, 1996, 35 (01) :43-55
[4]   Intravascular contrast agent-enhanced MRI measuring contrast clearance and tumor blood volume and the effects of vascular modifiers in an experimental tumor [J].
Bentzen, L ;
Vestergaard-Poulsen, P ;
Nielsen, T ;
Overgaard, J ;
Bjornerud, A ;
Briley-Sæbo, K ;
Horsman, MR ;
Ostergaard, L .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (04) :1208-1215
[5]  
Bjornerud A, 2000, MAGNET RESON MED, V44, P803, DOI 10.1002/1522-2594(200011)44:5<803::AID-MRM19>3.0.CO
[6]  
2-K
[7]   Assessment of T1 and T*2 effects in vivo and ex vivo using iron oxide nanoparticles in steady state-dependence on blood volume and water exchange [J].
Bjornerud, A ;
Johansson, LO ;
Briley-Sæbo, K ;
Ahlström, HK .
MAGNETIC RESONANCE IN MEDICINE, 2002, 47 (03) :461-471
[8]   Pre-clinical results with Clariscan™ (NC100150 Injection);: experience from different disease models [J].
Bjornerud, A ;
Johansson, LO ;
Ahlström, HK .
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE, 2001, 12 (2-3) :99-103
[9]   Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent [J].
Bourrinet, P ;
Bengele, HH ;
Bonnemain, B ;
Dencausse, A ;
Idee, JM ;
Jacobs, PM ;
Lewis, JM .
INVESTIGATIVE RADIOLOGY, 2006, 41 (03) :313-324
[10]  
Bremer C, 1999, JMRI-J MAGN RESON IM, V10, P461, DOI 10.1002/(SICI)1522-2586(199909)10:3<461::AID-JMRI30>3.3.CO